BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38513500)

  • 1. NPS-EQA PART II: Four years' experience in external quality assessment program in Italy for classical and new psychoactive substances analysis in hair.
    Rotolo MC; Graziano S; Varì MR; Minutillo A; Di Giorgi A; Aquilina V; Pichini S; Marchei E
    J Pharm Biomed Anal; 2024 Jun; 243():116100. PubMed ID: 38513500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NPS-EQA PART I: Four years' experience in external quality assessment program in Italy for classical and new psychoactive substances analysis in oral fluid.
    Marchei E; Graziano S; Varì MR; Minutillo A; Aquilina V; Pichini S; Rotolo MC
    J Pharm Biomed Anal; 2024 Jun; 243():116084. PubMed ID: 38452420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical and health governance aspects of the external quality assessment system for classical and new psychoactive substances analysis testing in blood.
    Di Gaudio F; Giaccone V; Cucina A; Indelicato S; Raso M; Brunacci G; Lundari A; Rotolo MC; Busardò F; La Rocca M
    J Pharm Biomed Anal; 2024 Aug; 245():116175. PubMed ID: 38728951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four years' experience in external proficiency testing programs for hair testing of drugs of abuse in Italy (HAIRVEQ) and comparison with the Society of Hair Testing program in 2005.
    Ventura M; Pichini S; Pujadas M; Ventura R; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; Jurado C; de la Torre R
    Ther Drug Monit; 2007 Feb; 29(1):11-9. PubMed ID: 17304145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ORALVEQ: external quality assessment scheme of drugs of abuse in oral fluid: results obtained in the first round performed in 2007.
    Ventura M; Ventura R; Pichini S; Leal S; Zuccaro P; Pacifici R; Langohr K; de la Torre R
    Forensic Sci Int; 2008 Nov; 182(1-3):35-40. PubMed ID: 19004584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HAIRVEQ: an external quality control scheme for drugs of abuse analysis in hair.
    Pichini S; Ventura M; Pujadas M; Ventura R; Pellegrini M; Zuccaro P; Pacifici R; de la Torre R
    Forensic Sci Int; 2004 Oct; 145(2-3):109-15. PubMed ID: 15451081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HAIRVEQ 2006: evolution of laboratories' performance after different educational actions.
    Ventura M; Stramesi C; Pichini S; Ventura R; Pujadas M; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; de la Torre R
    Forensic Sci Int; 2008 Mar; 176(1):2-8. PubMed ID: 17980986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with external quality assessment of drugs of abuse testing in the Lombardy Region in Italy.
    Cassani M; Giuliani L; Amigoni M; Buratta A; Marocchi A
    Clin Chem Lab Med; 2002 Feb; 40(2):156-64. PubMed ID: 11939489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.
    Niebel A; Pragst F; Krumbiegel F; Hartwig S
    Forensic Sci Int; 2022 Feb; 331():111148. PubMed ID: 34923263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy.
    La Maida N; Di Giorgi A; Pichini S; Pellegrini M; Di Trana A; Elmo MG; Polselli GM; Casella P; Di Stefano A; Ducci G
    Ther Drug Monit; 2024 Apr; 46(2):203-209. PubMed ID: 38018870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of SARS-CoV-2 nucleic acid amplification testing in Austria as measured by external quality assessment schemes during 3 years of the COVID-19 pandemic: an observational retrospective study.
    Buchta C; Aberle SW; Allerberger F; Benka B; Görzer I; Griesmacher A; Hübl W; Huf W; Kapiotis S; Müller MM; Neuwirth E; Puchhammer-Stöckl E; Weseslindtner L; Camp JV
    Lancet Microbe; 2023 Dec; 4(12):e1015-e1023. PubMed ID: 37979591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Round of External Quality Assessment Scheme for SARS-CoV-2 Laboratories During the COVID-19 Pandemic in Thailand.
    Saeng-Aroon S; Changsom D; Boonmuang R; Waicharoen S; Buayai K; Okada P; Uppapong B; Chittaganpitch M; Soisangwan P; Praphasiri P; Skaggs BA
    Health Secur; 2023; 21(3):183-192. PubMed ID: 37196204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and application of a method for the quantification of 137 drugs of abuse and new psychoactive substances in hair.
    Barone R; Pelletti G; Giorgetti A; Mohamed S; Pascali JP; Sablone S; Introna F; Pelotti S
    J Pharm Biomed Anal; 2024 Jun; 243():116054. PubMed ID: 38422647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Licit and Illicit Drugs Use during Pregnancy in Mexican Women.
    Gómez-Ruiz LM; Marchei E; Rotolo MC; Brunetti P; Mannocchi G; Acosta-López A; Ramos-Gutiérrez RY; Varela-Busaka MB; Pichini S; Garcia-Algar O
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: results of the first italian external quality assurance scheme.
    Marchetti A; Barberis M; Papotti M; Rossi G; Franco R; Malatesta S; Buttitta F; Ardizzoni A; Crinò L; Gridelli C; Taddei GL; Clemente C; Scagliotti G; Normanno N; Pinto C
    J Thorac Oncol; 2014 Oct; 9(10):1470-6. PubMed ID: 25170637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proficiency testing for psychoactive substances in Italy.
    Ferrara SD; Brusini G; Maietti S; Frison G; Castagna F; Allevi S; Menegus AM; Tedeschi L
    Int J Legal Med; 1999; 113(1):50-4. PubMed ID: 10654240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences.
    Normanno N; Pinto C; Castiglione F; Fenizia F; Barberis M; Marchetti A; Fontanini G; De Rosa G; Taddei GL
    J Transl Med; 2015 Sep; 13():287. PubMed ID: 26335936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDC's Vitamin A Laboratory-External Quality Assessment Program Shows Little Change in Laboratory Performance for Multiple Nutritional Biomarkers over a 10-Year Period (2008-2017).
    Chaudhary-Webb M; Zhang M; Pfeiffer CM
    J Nutr; 2023 Jan; 153(1):373-384. PubMed ID: 36913474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Italian External Quality Assessment Program for Cystic Fibrosis Sweat Chloride Test: Does Active Participation Improve the Quality?
    Salvatore M; Amato A; Floridia G; Censi F; Ferrari G; Tosto F; Padoan R; Raia V; Cirilli N; Castaldo G; Capoluongo E; Caruso U; Corbetta C; Taruscio D
    Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32375358
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.